top of page

Enjoy Eating Healthy by Trusting Your Gut Feeling
GLP-1 and metabolic health


From “Type 3 Diabetes” to Incretin Therapies: Can GLP-1 Drugs Modify Alzheimer’s Disease Progression?
GLP-1 and Alzheimer's Disease: The Metabolic Hypothesis of Type 3 Diabetes For many years, Alzheimer’s disease was explained almost exclusively in terms of beta-amyloid plaque accumulation and tau protein tangles. Over the past two decades, however, metabolic research has shifted part of the focus toward another mechanism: impaired insulin signalling in the brain. In 2008, de la Monte and Wands introduced the concept of “type 3 diabetes,” observing that Alzheimer’s brains sh
Claudia Gravaghi


The Future of GLP-1 Receptor Drugs: Oral GLP-1 and New Trends by 2028
The landscape of GLP-1 (Glucagon-Like Peptide-1) receptor agonists is evolving at a breakneck pace. Originally developed for Type 2 diabetes , these drugs have reshaped metabolic medicine and are now at the forefront of obesity, cardiometabolic, and broader therapeutic research . Over the next two years (2026–2028) , we expect dramatic innovation that will redefine how we treat metabolic health. New Drug Modalities & Approvals Oral GLP-1 Receptor Drugs Future— Game Changers
Claudia Gravaghi


Is the Ketogenic Diet really a revolutionary approach?
Review of "Fat for Fuel" a book by Joseph Mercola: Fat for Fuel: A Revolutionary Diet to Combat Cancer, Boost Brain Power, and Increase Your Energy One of the most comprehensive guides to the ketogenic diet. Welcome to THE SMART BELLY Blog Enjoy Eating Healthy by Trusting Your Gut Feeling Ketogenic Diet, Cancer Prevention Diet, Brain Cancer Diet The ketogenic diet is very popular these days, and I am often asked for opinions on this radical approach. This diet goes back to D

Claudia Gravaghi
bottom of page
